Arbutus Biopharma Presents Preclinical Data at the 2015 International Meeting on Molecular Biology of Hepatitis B Viruses
October 06, 2015 at 08:31 AM EDT
Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading therapeutic solutions company focused on developing a cure for ...